Form 4: Amgen SVP & CCO Nancy Grygiel Reports Stock Transactions
SEC Form 4 Filing
Nancy Grygiel, SVP & CCO of Amgen, reports the disposition of 114 shares of common stock to cover tax obligations related to vesting Restricted Stock Units (RSUs).
Summary
- On May 2, 2024, Nancy Grygiel, SVP & CCO of Amgen, filed a Form 4 with the SEC.
- The filing reports the disposition of 114 shares of Amgen common stock at a price of $277.37 per share.
- This transaction was to cover tax obligations related to the vesting of Restricted Stock Units (RSUs).
- Following the transaction, Grygiel directly owns 12,000 shares of Amgen common stock.
- Grygiel also indirectly owns 99.9653 shares through the 401(k) Plan.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, which carries a neutral sentiment.
Industry Context
Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine sale of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 05/02/2024 | Date of transaction and filing. |
| 05/05/2024 | 144 RSUs will vest. |
| 07/31/2024 | 2,780 RSUs will vest. |
| 04/30/2025 | 199 RSUs will vest. |
| 05/02/2025 | 214 RSUs will vest. |
| 05/02/2026 | 210 + 221 RSUs will vest. |
| 05/02/2027 | 216 RSUs will vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.